Search Results for 'Ticagrelor'

Ticagrelor published presentations and documents on DocSlides.

Ticagrelor compared with clopidogrel in patients with acute
Ticagrelor compared with clopidogrel in patients with acute
by tatyana-admore
PLAT. elet Inhibition and patient . O. utcomes tr...
Prasugrel  vs  ticagrelor in acute coronary syndromes
Prasugrel vs ticagrelor in acute coronary syndromes
by tawny-fly
Giuseppe . Biondi-Zoccai. , MD. Sapienza Universi...
One-month Ticagrelor Monotherapy After     PCI in Acute Coronary Syndromes:
One-month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes:
by yvonne
Principal Results From the Double-blind, Placebo-c...
Predictive
Predictive
by kittie-lecroy
safety study . of . ticagrelor's. degradation co...
Predictive
Predictive
by lindy-dunigan
safety study . of . ticagrelor's. degradation co...
Long-Term Tolerability of
Long-Term Tolerability of
by briana-ranney
Ticagrelor. for Secondary Prevention: . Insights...
Reduction in Ischemic Events with
Reduction in Ischemic Events with
by natalia-silvester
Ticagrelor. in Diabetic Patients from the PEGASU...
Antiplatelet Agents Mohammad Sistanizad
Antiplatelet Agents Mohammad Sistanizad
by blindnessinfluenced
Associate Professor of Clinical Pharmacy,. SBMU. C...
T icagrelor  W ith Asp I
T icagrelor W ith Asp I
by terrificycre
rin or A. L. one . I. n Hi. GH. -Risk Patients Aft...
wvwvyzwvxv
wvwvyzwvxv
by eddey
coronary intervention PCI1920 As new antithromboti...
Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC
Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC
by eloise
ORIGIN. Pierre . Amarenco. , Hans . Denison. , . S...
Aspirin (n = 6,610) Ticagrelor
Aspirin (n = 6,610) Ticagrelor
by danya
(n . = 6,589). SOCRATES. Primary outcome, death, M...
Francesco Franchi, MD, Fabiana Rollini, MD, Jose Rivas Rios, MD, Andrea Rivas, MD,
Francesco Franchi, MD, Fabiana Rollini, MD, Jose Rivas Rios, MD, Andrea Rivas, MD,
by shiloh201
Malhar Agarwal, MD, Megha Kureti, MD, Deepa Nagara...
Canadian Diabetes Association Clinical Practice Guidelines
Canadian Diabetes Association Clinical Practice Guidelines
by test
Acute Coronary Syndromes and Diabetes. Chapter 26...
ACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club
by tatiana-dople
Announcements . Thank you attending the ACCP Card...
STEMI Update 2017 Cardiology Today
STEMI Update 2017 Cardiology Today
by alida-meadow
Michael C Fraizer, MD. Iowa Heart Center. Feb 4, ...
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Bonferroni: Friend or Foe?
Bonferroni: Friend or Foe?
by alexa-scheidler
Multiple Testing in Cardiovascular Medicine. Dhru...
Antiplatelet  Therapy for Secondary Prevention in the First Year Following
Antiplatelet Therapy for Secondary Prevention in the First Year Following
by calandra-battersby
Antiplatelet Therapy for Secondary Prevention in...
ACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club
by marina-yarberry
ACCP Cardiology PRN Journal Club 27 September 20...
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
by GratefulHeart
Akhtar . Fajar. . Muzakkir. New ESC NSTEMI Guidel...
Cangrelor : Friend or Foe? -
Cangrelor : Friend or Foe? -
by ariel
Cangrelor. : Not the CHAMPION We Hoped For. James ...
Practice Plus Webinar June 23
Practice Plus Webinar June 23
by bitsy
rd. . 2021 . Steve Williams. Lead Clinical Pharma...